Immuneering Corp
Biotechnology
Healthcare
IMRX
35.53 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.40
52 week high
9.26
high
9.65
52 week low
0.00
low
8.40
growth
167.60 %
previous Close
8.73
P/E ratio
market cap
128 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top